Rare
lephants
Screener
Toggle theme
Adaptive Biotechnologies Corporation
ADPT
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Revenue Breakdown
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Revenue Breakdown
←
5Y
10Y
MAX
→
Revenue Breakdown
Chart
Table
MRD
Immune Medicine
Fiscal Year
MRD
Immune Medicine
FY2024
$145.5M
$33.4M
FY2025
$212.3M
$64.6M
Download CSV
